CCR5 and HIV infectious disease: Our data show that dopamine has bimodal effects on the CCR5 inhibitor Maraviroc on HIV infection in human monocyte-derived macrophages (hMDM), reducing its effectiveness in hMDM from some individuals and enhancing its effectiveness in others.